In the case of Corcept Therapeutics Incorporated (NASDAQ: CORT), what’s next?

The closing price of Corcept Therapeutics Incorporated (NASDAQ: CORT) was $24.17 for the day, up 1.00% from the previous closing price of $23.93. In other words, the price has increased by $+0.24 from its previous closing price. On the day, 581694 shares were traded. CORT stock price reached its highest trading level at $24.27 during the session, while it also had its lowest trading level at $23.64.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…



Our analysis of CORT’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.50 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 18.93. For the most recent quarter (mrq), Quick Ratio is recorded 8.40 and its Current Ratio is at 8.50. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

On July 27, 2022, Jefferies Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $21 to $35.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 01 when Maduck Sean sold 625 shares for $25.28 per share. The transaction valued at 15,800 led to the insider holds 56,462 shares of the business.

Robb Gary Charles sold 186 shares of CORT for $4,842 on Nov 23. The Chief Business Officer now owns 21,143 shares after completing the transaction at $26.03 per share. On Nov 22, another insider, Robb Gary Charles, who serves as the Chief Business Officer of the company, sold 4,814 shares for $26.03 each. As a result, the insider received 125,308 and left with 21,329 shares of the company.

Valuation Measures:

As of this moment, Corcept’s Price-to-Earnings (P/E) ratio for their current fiscal year is 24.32, and their Forward P/E ratio for the next fiscal year is 22.59. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.48 while its Price-to-Book (P/B) ratio in mrq is 5.47.

Stock Price History:

Over the past 52 weeks, CORT has reached a high of $30.14, while it has fallen to a 52-week low of $16.47. The 50-Day Moving Average of the stock is 22.91, while the 200-Day Moving Average is calculated to be 24.39.

Shares Statistics:

CORT traded an average of 735.33K shares per day over the past three months and 612.11k shares per day over the past ten days. A total of 107.12M shares are outstanding, with a floating share count of 95.67M. Insiders hold about 0.50% of the company’s shares, while institutions hold 81.80% stake in the company. Shares short for CORT as of Oct 13, 2022 were 17.19M with a Short Ratio of 14.00M, compared to 17.07M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 16.05% and a Short% of Float of 24.79%.

Earnings Estimates

The firm’s stock currently is rated by 4 analysts. On average, analysts expect EPS of $0.22 for the current quarter, with a high estimate of $0.24 and a low estimate of $0.21, while EPS last year was $0.24. The consensus estimate for the next quarter is $0.23, with high estimates of $0.26 and low estimates of $0.22.

Analysts are recommending an EPS of between $0.94 and $0.87 for the fiscal current year, implying an average EPS of $0.89. EPS for the following year is $1.03, with 4 analysts recommending between $1.21 and $0.83.

Revenue Estimates

A total of 6 analysts have provided revenue estimates for CORT’s current fiscal year. The highest revenue estimate was $425.07M, while the lowest revenue estimate was $412M, resulting in an average revenue estimate of $416.67M. In the same quarter a year ago, actual revenue was $365.98M, up 13.90% from the average estimate. Based on 6 analysts’ estimates, the company’s revenue will be $463.21M in the next fiscal year. The high estimate is $502.3M and the low estimate is $430.9M. The average revenue growth estimate for next year is up 11.20% from the average revenue estimate for this year.